Cargando…
Pricing Treatments Cost-Effectively when They Have Multiple Indications: Not Just a Simple Threshold Analysis
BACKGROUND: Economic evaluations of treatments increasingly employ price-threshold analyses. When a treatment has multiple indications, standard price-threshold analyses can be overly simplistic. We examine how rules governing indication-specific prices and reimbursement decisions affect value-based...
Autores principales: | Goldhaber-Fiebert, Jeremy D., Cipriano, Lauren E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625719/ https://www.ncbi.nlm.nih.gov/pubmed/37698120 http://dx.doi.org/10.1177/0272989X231197772 |
Ejemplares similares
-
Population Health and Cost-Effectiveness Implications of a “Treat All” Recommendation for HCV: A Review of the Model-Based Evidence
por: Cipriano, Lauren E., et al.
Publicado: (2018) -
Cost-Effectiveness Analysis of Risk-Factor Guided and Birth-Cohort Screening for Chronic Hepatitis C Infection in the United States
por: Liu, Shan, et al.
Publicado: (2013) -
Estimating the cost of cervical cancer screening in five developing countries
por: Goldhaber-Fiebert, Jeremy D, et al.
Publicado: (2006) -
Cost Effectiveness of Fibrosis Assessment Prior to Treatment for Chronic Hepatitis C Patients
por: Liu, Shan, et al.
Publicado: (2011) -
Modeling the Cost-Effectiveness of Interventions to Prevent Plague in Madagascar
por: Malloy, Giovanni S. P., et al.
Publicado: (2021)